Sort
23,748 grants matching “melanoma”
Low dose interleukin 2 for the expansion of regulatory T cells and the treatment of moderate to severe ulcerative colitis
$235,913Scott B Snapper · Boston Children'S Hospital · R21 · FY2018 · DK
Development of a Novel Immunotherapy Platform for Triple-Negative Breast Cancer
$235,901Craig M. Brackett · Roswell Park Cancer Institute Corp · R21 · FY2021 · CA
RECOMBINANT LISTERIA VACCINES FOR MELANOMA
$235,900University Of California Los Angeles · R01 · FY2000 · CA
CORE--Pathology Core B: U. of PA consortium
$235,838David E E Elder · Wistar Institute · P01 · FY2007 · CA
HSP70 as a Novel Therapeutic Target for Melanoma
$235,803Maureen E Murphy · Wistar Institute · P01 · FY2016 · CA
Suppressing Radiotherapy-Induced Metastasis in Aggressive Breast Cancers via 'On-Demand' siRNA Delivery from Responsive Polymer Nanoparticles
$235,766Millicent O Sullivan · University Of Delaware · R21 · FY2020 · EB
T CELL RESPONSE TO GENETICALLY ENGINEERED AND MATURED DC
$235,761University Of Connecticut Sch Of Med/Dnt · R01 · FY2001 · CA
Study of TCR Engineering Against Melanoma in Mice
$235,754David Baltimore · California Institute Of Technology · P01 · FY2014 · CA
Invasive Behavior of Tumor Cells Producing Collagenase-1
$235,742Constance E Brinckerhoff · Dartmouth College · R01 · FY2011 · CA
Invasive Behavior of Tumor Cells Producing Collagenase-1
$235,742Constance E Brinckerhoff · Dartmouth College · R01 · FY2012 · CA
Biogenesis of Melanosomes
$235,737Seth J. Orlow · New York University School Of Medicine · R01 · FY2014 · AR
Eastern Cooperative Oncology Group
$235,668Mayo Clinic · U10 · FY2004 · CA
Biostatistics and Bioinformatics Core
$235,628Phyllis A Gimotty · Wistar Institute · P50 · FY2023 · CA
Multiscale modeling of leukocyte-tumor cell adhesion to endothelium in shear flow
$235,598Cheng Dong · Pennsylvania State University, The · R01 · FY2009 · CA
Peptide-amphiphile biomimetics for targeted therapies
$235,554Gregg B Fields · Florida Atlantic University · R01 · FY2007 · EB
HSP70 as a Novel Therapeutic Target for Melanoma
$235,512Maureen E Murphy · Wistar Institute · P01 · FY2014 · CA
Pre-clinical Translation of Regulatory T-cell Inhibition in Brain Tumors
$235,500John H Sampson · Duke University · R21 · FY2010 · NS
Development of a research infrastructure for understanding and addressing multiple melanoma disparities.
$235,500Primo N Lara · University Of California At Davis · P30 · FY2018 · CA
Protein/Polymer Devices for Slow-Release of Immunotherapies to Treat Ovarian Cancer
$235,500Jonathan Kyle Pokorski · University Of California, San Diego · R21 · FY2018 · EB
Defining a New Role for Alpha-MSH: Antioxidant in UVB-Irradiated Melanocytes
$235,500Ana Luisa Kadekaro · University Of Cincinnati · R21 · FY2010 · ES
INVESTIGATING EPIGENOMIC REPROGRAMMING IN HUMAN MELANOMA DEVELOPMENT
$235,500The Leland Stanford Junior University · · FY2017 · Department of the Army
Neuroimmunology of Vaccines in Adoptive T-cell Therapy for Brain Tumor
$235,500John H Sampson · Duke University · R21 · FY2010 · NS
The B7x pathway in the tumor microenvironment
$235,486Xingxing Zang · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · CA
Animal Model Core
$235,461Jason A Chesney · University Of Louisville · P30 · FY2017 · GM
Animal Model Core
$235,461Jason A Chesney · University Of Louisville · P30 · FY2013 · GM